Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.
BACKGROUND
Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site infections among IDUs in England.


METHODS
Unlinked-anonymous survey during 2003/05 recruiting IDUs from community settings at seven locations across England. Self-reported injecting practice, symptoms of injection site infections (abscess or open wound) and health service utilisation data were collected using a questionnaire, participants also provided dried blood spot samples (tested for markers blood borne virus infections). Cost estimates were obtained by combining questionnaire data with information from national databases and the scientific literature.


RESULTS
36% of the 1,058 participants reported an injection site infection in the last year. Those reporting an injection site infection were more likely to be female and aged over 24, and to have: injected into legs, groin, and hands in last year; injected on 14 or more days during the last four weeks; cleaned needles/syringes for reuse; injected crack-cocaine; antibodies to hepatitis C; and previously received prescribed substitute drug. Two-thirds of those with an injection site infection reported seeking medical advice; half attended an emergency department and three-quarters of these reported hospital admission. Simple conservative estimates of associated healthcare costs range from pound 15.5 million per year to as high as pound 30 million; though if less conservative unit costs assumptions are made the total may be much higher (pound 47 million). The vast majority of these costs are due to hospital admissions and the uncertainty is due to little data on length of hospital stays.


CONCLUSIONS
Symptoms of injection site infections are common among IDUs in England. The potential costs to the health service are substantial, but these costs need more accurate determination. Better-targeted interventions to support safer injection need to be developed and evaluated. The validity of self-reported symptoms, and the relationship between symptoms, infection severity, and health seeking behaviour require further research.
Hope
Vivian
V
Centre for Infections, Health Protections Agency, London, UK. vivian.hope@hpa.org.uk
Kimber
Jo
J
Vickerman
Peter
P
Hickman
Matthew
M
Ncube
Fortune
F
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000553:Ambulatory Care / Q000706:statistics & numerical data; D001424:Bacterial Infections / Q000191:economics* / Q000453:epidemiology*; D055030:Drug Users; D004739:England; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007239:Infections / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009819:Office Visits / Q000706:statistics & numerical data; D012737:Sex Factors; D015819:Substance Abuse, Intravenous / Q000150:complications*; D011795:Surveys and Questionnaires
BMJ. 2005 Jan 29;330(7485):208-9
15677636
Emerg Infect Dis. 2007 Oct;13(10):1510-1
18257999
Clin Infect Dis. 2000 Mar;30(3):579-81
10722447
Addiction. 1993 Dec;88(12):1617-26
8130701
Drug Alcohol Depend. 2001 Mar 1;62(1):77-82
11173170
J Viral Hepat. 2007 Sep;14(9):645-52
17697017
Scott Med J. 1987 Apr;32(2):41-5
3602985
Ann Intern Med. 1993 Nov 15;119(10):1017-28
8214979
Soc Sci Med. 2000 Jun;50(12):1703-13
10798326
Stat Methods Med Res. 2009 Aug;18(4):361-79
19036917
Aust N Z J Public Health. 2008 Feb;32(1):34-7
18290911
Emerg Infect Dis. 2008 Feb;14(2):202-9
18258111
J Clin Epidemiol. 1996 Oct;49(10):1149-54
8826995
Addiction. 2006 Oct;101(10):1384-93
16968336
J Urban Health. 2003 Mar;80(1):127-36
12612102
Addiction. 2005 Nov;100(11):1701-8
16277630
Addiction. 2007 Nov;102(11):1782-90
17784900
J Public Health (Oxf). 2005 Mar;27(1):62-6
15564279
Am J Public Health. 2002 Dec;92(12):1915-7
12453808
Clin Infect Dis. 2001 Jul 1;33(1):35-40
11389492
Arch Surg. 2002 Nov;137(11):1217-22
12413304
Harm Reduct J. 2005 Nov 10;2:24
16281979
Br J Dermatol. 2004 Jan;150(1):1-10
14746612
J Bone Joint Surg Am. 1994 Oct;76(10):1526-30
7929500
Addiction. 1997 Oct;92(10):1349-52
9489051
CMAJ. 2001 Aug 21;165(4):415-20
11531049
Public Health Rep. 1992 Sep-Oct;107(5):595-8
1410243